REMEGEN (09995) appointed Liang Wei as the securities affairs representative.
Rongchang Biology (09995) announced that on June 16, 2026, the company held the first meeting of the third board of directors, and reviewed and approved the proposal on the appointment of the company's securities affairs representative. It agreed to appoint Mr. Liang Wei as the company's securities affairs representative for a term of three years, from the date of approval by this board of directors to the expiration date of the term of the third board of directors.
REMEGEN (09995) announced that on June 16, 2026, the company held the first meeting of the third board of directors to review and approve the proposal "Regarding the Appointment of the Company's Securities Affairs Representative." It was agreed to appoint Mr. Liang Wei as the company's securities affairs representative for a term of three years, starting from the date of approval by this board of directors until the expiration of the term of the third board of directors.
Related Articles
US Stock Market Move | Fox-A (FOXA.US) continued to fall by over 5%, with a total drop of 25% in 3 days.
US Stock Market Move | Announced to receive a $50 million intention fund from the United States chip act, Coherent (COHR.US) drops more than 5%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. and ADR have reached a ten-year cooperation agreement. AMKR.US jumped over 11% in early trading.
US Stock Market Move | Fox-A (FOXA.US) continued to fall by over 5%, with a total drop of 25% in 3 days.
US Stock Market Move | Announced to receive a $50 million intention fund from the United States chip act, Coherent (COHR.US) drops more than 5%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. and ADR have reached a ten-year cooperation agreement. AMKR.US jumped over 11% in early trading.
RECOMMEND
